Congenital muscular dystrophies: a brief review

Semin Pediatr Neurol. 2011 Dec;18(4):277-88. doi: 10.1016/j.spen.2011.10.010.

Abstract

Congenital muscular dystrophies (CMDs) are clinically and genetically heterogeneous neuromuscular disorders with onset at birth or in infancy in which the muscle biopsy is compatible with a dystrophic myopathy. In the past 10 years, knowledge of neuromuscular disorders has dramatically increased, particularly with the exponential boost of disclosing the genetic background of CMDs. This review will highlight the clinical description of the most important forms of CMD, paying particular attention to the main keys for diagnostic approach. The diagnosis of CMDs requires the concurrence of expertise in multiple specialties (neurology, morphology, genetics, neuroradiology) available in a few centers worldwide that have achieved sufficient experience with the different CMD subtypes. Currently, molecular diagnosis is of paramount importance not only for phenotype-genotype correlations, genetic and prenatal counseling, and prognosis and aspects of management, but also concerning the imminent availability of clinical trials and treatments.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Collagen Type VI / deficiency
  • Genetic Association Studies
  • Humans
  • Laminin / genetics
  • Muscle, Skeletal / pathology
  • Muscular Dystrophies / congenital*
  • Muscular Dystrophies / diagnosis*
  • Muscular Dystrophies / genetics
  • Phenotype

Substances

  • Collagen Type VI
  • Laminin